Volume 5, Issue 4 (Multidisciplinary Cancer Investigation 2021)                   Multidiscip Cancer Investig 2021, 5(4): 1-2 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheikhi-Mobarakeh Z, Yarmohammadi H, Montazeri A. The Impact of COVID-19 Pandemic on Lymphedema Visits in the lymphedema Clinic at Motamed Cancer InstituteThe Impact of COVID-19 Pandemic on Lymphedema Fol- low-ups in the Lymphedema Clinic at Motamed Cancer Institute. Multidiscip Cancer Investig 2021; 5 (4) :1-2
URL: http://mcijournal.com/article-1-316-en.html
1- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran & Integrative Oncology Research Group, Breast Cancer Research Center, Mota- med Cancer Institute, ACECR, Tehran, Iran
2- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran & Medical Students Research Committee, Shahed University, Tehran, Iran
3- Population Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran , montazeri@acecr.ac.ir
Abstract:   (1084 Views)
The COVID-19 pandemic has greatly  changed the routine medical practice in any field and the care delivery to lymphedema patients is not an exception. The lymphedema clinic at Motamed Cancer Institute (MCI), Tehran primarily was established for the management of breast cancer- related lymphedema (BCRL). However, it is now a referral center for different types of lymphedema from all over Iran. This letter aimed to show the impact of the coronavirus disease 2019 (COVID-19) pandemic on the lymphedema practice in the MCI lymphedema clinic.
Full-Text [PDF 213 kb]   (759 Downloads)    
Select article type: Letters to the Editor |
Received: 2021/03/24 | Accepted: 2021/12/28 | ePublished: 2021/12/28

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb